Studies with complete reporting and rigorous design were rated as "High," while others with some limitations or missing methodological details were rated as "Medium" or "Low." To evaluate the reliability and scientific rigor of the evidence presented in this review, we conducted a methodological quality assessment of the primary clinical trials included
Discontinue use and consult your doctor if any adverse effects occur
No peer-reviewed human trials examining the specific efficacy of over-the-counter botanical supplement patches for GLP-1 pathway support have been published as of this review
Pharmacokinetic and pharmacodynamic effects of multiple-dose administration of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in obese participants with and without type 2 diabetes mellitus
The carefully designed titration schedule for tirzepatide dosing for weight loss in units, starting at 2.5 mg and potentially escalating to 15 mg weekly, balances effectiveness with tolerability
Reduced glucagon production lowers blood glucose levels